United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
528.47
-1.06 (-0.20%)
Jul 24, 2026, 4:00 PM EDT - Market closed
United Therapeutics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, United Therapeutics stock has a consensus rating of "Buy" and an average price target of $663.23. The average 1-year stock price forecast is 25.50% higher than the current stock price, while the lowest is $516 (-2.36%) and the highest is $750 (+41.92%).
Price Target: $663.23 (+25.50%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 1 | 2 | 3 | 3 | 3 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $687 | Buy | Maintains | $687 | +30.00% | Jul 23, 2026 |
| Jefferies | Jefferies | Buy Maintains $733 → $714 | Buy | Maintains | $733 → $714 | +35.11% | Jul 10, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $620 → $613 | Hold | Reiterates | $620 → $613 | +16.00% | Jul 10, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $701 → $704 | Buy | Maintains | $701 → $704 | +33.21% | Jul 7, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 29, 2026 |
Financial Forecast
Revenue This Year
3.24B
from 3.18B
Increased by 1.67%
Revenue Next Year
3.68B
from 3.24B
Increased by 13.73%
EPS This Year
27.50
from 27.86
Decreased by -1.28%
EPS Next Year
33.03
from 27.50
Increased by 20.10%
EPS and Forward PE are based on non-GAAP adjusted numbers.